Physician profile
David Pai
NPI 1134173222
$1,850.01
in general payments reported to CMS, 2019-2025
17 companies · $229 in 2025
The $229 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $227 · 2021: $84.90 · 2022: $356 · 2023: $111 · 2024: $166 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $351.31 | 2019-2023 | Veltassa |
| Astrazeneca Pharmaceuticals Lp | $305.45 | 2019-2022 | |
| Opko Pharmaceuticals, LLC | $280.61 | 2019-2023 | Rayaldee |
| Akebia Therapeutics INC | $195.29 | 2019-2025 | Vafseo, Auryxia |
| Fresenius USA Marketing, INC. | $160.19 | 2019-2024 | |
| Medtronic, INC. | $122.24 | 2025 | Symplicity G3 |
| Mallinckrodt Enterprises LLC | $99.99 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $74.15 | 2019-2025 | Jynarque |
| Alexion Pharmaceuticals, INC. | $67.63 | 2024 | |
| Novartis Pharmaceuticals Corporation | $35.35 | 2024-2025 | |
| Daiichi Sankyo INC. | $32.55 | 2020-2023 | Injectafer |
| Mallinckrodt Hospital Products INC. | $31.61 | 2020-2022 | |
| Amgen INC. | $28.42 | 2019-2020 | |
| Nxstage Medical, INC. | $17.97 | 2020 | |
| Glaxosmithkline, LLC. | $16.98 | 2023 | Benlysta, Jesduvroq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $16.59 | 2024 | Ibsrela |
| Aurinia Pharma U.S., INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.